journal article·2025-12Open access

Antimicrobial Multi‐Assay Evaluation of (Al‐Doped ZnO)‐Ag and TiO 2 ‐Ag Nanocoatings: Impact of Direct and Indirect Mechanisms

Damiano Squitieri, Roberta Vitali, Cecilia Bartoleschi, Giulia Lombardini, Margherita Cacaci, Lorenzo Degli Esposti, Camilla Fusacchia, Skerxho Osmani, Luca Gavioli, Francesca Bugli, Daniele Valerini

Advanced Materials Interfaces· Volume 12· Issue 23

Abstract

Abstract Infectious diseases caused by pathogenic bacteria, fungi, and viruses pose a global health threat, aggravated by antimicrobial resistance (AMR). This study explores the antimicrobial efficacy of two nanostructured composite coatings —aluminum‐doped zinc oxide with silver (AZO‐Ag) and titanium dioxide with silver (TiO 2 ‐Ag)— on polyester substrates, against high‐priority pathogens: susceptible and resistant Klebsiella pneumoniae and Staphylococcus aureus bacterial strains, Candida albicans clinical fungal strain, and H1N1 influenza virus. A multimodal analytical approach, encompassing SEM, live/dead fluorescence assays, CFU counts, RT‐qPCR, and immunofluorescence, supported by ROS quantification, is adopted to evaluate antimicrobial activity and contribution of indirect and direct‐contact mechanisms. Both coatings exhibit robust antimicrobial effects especially through indirect mechanisms, with TiO 2 ‐Ag generally more effective than AZO‐Ag through indirect interactions while AZO‐Ag more effective in some direct‐contact scenarios. Bacterial reduction up to ≈99% and viral inactivation of 98% are observed. Cytotoxicity assays reveal some decline in fibroblast viability, underscoring the coatings’ potential mainly for non‐clinical applications, like packaging or high‐touch surfaces. Moreover, the study emphasizes limitations in using single antimicrobial tests and necessity of combining diverse methodologies to comprehensively assess performance and mechanisms of action, finally proposing strategic guidelines for selecting appropriate antimicrobial materials and evaluation techniques tailored to specific application contexts.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Nanoparticles: synthesis and applications · Quantum Dots Synthesis And Properties · Advanced Nanomaterials in Catalysis

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Basic Biotechnological Sciences Intensive and Perioperative Clinics Università Cattolica del Sacro Cuore Rome 00168 Italy

ENEA – Italian National Agency for New Technologies Energy and Sustainable Economic Development Division Biotechnologies BIOTEC‐RED Via Anguillarese 301 Rome 00123 Italy

Department of Chemistry and Industrial Chemistry University of Genova Via Dodecaneso 31 Genova 16146 Italy

Institute of Science Technology and Sustainability for Ceramics (ISSMC) National Research Council (CNR) Via Granarolo 64 Faenza 48018 Italy

Department of Mathematical Physical and Computer Sciences University of Parma Parco Area delle Scienze 7/A Parma PR 43124 Italy

Interdisciplinary Laboratories for Advanced Materials Physics (i‐LAMP) & Dipartimento di Matematica e Fisica Università Cattolica del Sacro Cuore via della Garzetta 46 Brescia 25131 Italy

Department of Laboratory and Infectious Disease Sciences Fondazione Policlinico Universitario A. Gemelli IRCCS Rome 00168 Italy

ENEA – Italian National Agency for New Technologies Energy and Sustainable Economic Development Brindisi research center S.S. 7 Appia ‐ km 706 Brindisi 72100 Italy

References (56)

Show source-provided references
1. 10.1016/S0140-6736(22)02185-710.1016/S0140-6736(22)02185-7 ↗
2. 10.1016/S0140-6736(21)02724-010.1016/S0140-6736(21)02724-0 ↗
3. 10.1016/S0140-6736(24)01867-110.1016/S0140-6736(24)01867-1 ↗
4. WHO Bacterial Priority Pathogens List 2024: Bacterial Pathogens of Public Health Importance to Guide Research Development and Strategies to Prevent and Control Antimicrobial Resistance World Health Organization Geneva2024.
5. 10.3389/fmicb.2025.155089410.3389/fmicb.2025.1550894 ↗
6. WHO Fungal Priority Pathogens List to Guide Research Development and Public Health Action World Health Organization Geneva2022.
7. 10.1111/j.1567-1364.2006.00117.x10.1111/j.1567-1364.2006.00117.x ↗
8. https://www.who.int/news‐room/fact‐sheets/detail/influenza‐(seasonal)(accessed: September 2025).
9. 10.1111/irv.7007310.1111/irv.70073 ↗
10. 10.1128/cmr.00186-2310.1128/cmr.00186-23 ↗
11. Leung M. H. Y. · Compr. Biotechnol. · 2019 · 6 · 96
12. 10.1002/adfm.20191002110.1002/adfm.201910021 ↗
13. 10.1021/acsnano.2c1248810.1021/acsnano.2c12488 ↗
14. 10.1002/slct.20250008010.1002/slct.202500080 ↗
15. 10.1021/acsami.4c1468910.1021/acsami.4c14689 ↗
16. 10.1021/acsami.2c2200310.1021/acsami.2c22003 ↗
17. 10.3390/coatings1103034510.3390/coatings11030345 ↗
18. 10.3390/nano1222396210.3390/nano12223962 ↗
19. 10.1016/j.nano.2015.02.02310.1016/j.nano.2015.02.023 ↗
20. 10.1016/j.tsf.2017.10.03810.1016/j.tsf.2017.10.038 ↗
21. 10.1007/s10853-019-04311-z10.1007/s10853-019-04311-z ↗
22. 10.1063/1.497877210.1063/1.4978772 ↗
23. 10.3390/ma1303078410.3390/ma13030784 ↗
24. 10.1007/s13204-015-0493-810.1007/s13204-015-0493-8 ↗
25. 10.1016/j.jallcom.2017.05.19010.1016/j.jallcom.2017.05.190 ↗
26. 10.1016/j.apsusc.2023.15801110.1016/j.apsusc.2023.158011 ↗
27. 10.1016/j.surfin.2024.10385610.1016/j.surfin.2024.103856 ↗
28. R. G. S. V.Prasad D.Basavaraju K. N.Rao C. S.Naveen J.Endrino A. R.Phani in2011 Int. Conf. Nanosci. Technol. Soc. Implic. NSTSI11 2011 pp.1–6.10.1109/NSTSI.2011.6111808 ↗
29. 10.1166/jnn.2019.1661510.1166/jnn.2019.16615 ↗
30. 10.3390/coatings1012123810.3390/coatings10121238 ↗
31. 10.1016/j.mseb.2024.11764910.1016/j.mseb.2024.117649 ↗
32. 10.1128/aem.02241-2110.1128/aem.02241-21 ↗
33. 10.1038/s43246-021-00153-y10.1038/s43246-021-00153-y ↗
34. 10.1016/j.progsurf.2016.09.00110.1016/j.progsurf.2016.09.001 ↗
35. 10.1016/j.mtbio.2021.10014810.1016/j.mtbio.2021.100148 ↗
36. 10.1021/acsami.3c1654610.1021/acsami.3c16546 ↗
37. 10.1007/s00784-015-1655-510.1007/s00784-015-1655-5 ↗
38. 10.1016/j.apmt.2019.10047310.1016/j.apmt.2019.100473 ↗
39. 10.1128/JB.01524-0610.1128/JB.01524-06 ↗
40. 10.1016/j.drup.2017.07.00310.1016/j.drup.2017.07.003 ↗
41. 10.3389/fcimb.2012.0003310.3389/fcimb.2012.00033 ↗
42. 10.1016/j.molliq.2022.12104610.1016/j.molliq.2022.121046 ↗
43. 10.1007/s10311-020-01033-610.1007/s10311-020-01033-6 ↗
44. 10.2147/IJN.S35513110.2147/IJN.S355131 ↗
45. 10.1016/j.clay.2023.10711210.1016/j.clay.2023.107112 ↗
46. 10.1007/s00204-013-1079-410.1007/s00204-013-1079-4 ↗
47. 10.3390/ph1709121610.3390/ph17091216 ↗
48. 10.1007/s13204-018-0863-010.1007/s13204-018-0863-0 ↗
49. European Commission Commission Regulation (EU) No 10/2011 of 14 January 2011 on Plastic Materials and Articles Intended to Come into Contact with Food. Consolidated Text Version of 16.03.2025 2025. Document no. 02011R0010‐20250316.
50. 10.3390/nano712044210.3390/nano7120442 ↗
51. 10.1038/s41579-024-01054-w10.1038/s41579-024-01054-w ↗
52. “EUCAST. Breakpoint Tables for Interpretation of MICs and Zone Diameters Version 14.0 2024” http://www.eucast.org (accessed: September 2025).
53. https://www.culturecollections.org.uk/nop/product/mdck‐siat1(accessed: September 2025).
54. “WHO information for molecular diagnosis of influenza virus ” 2021 https://www.who.int/teams/global‐influenza‐programme/laboratory‐network/quality‐assurance/eqa‐project/information‐for‐molecular‐diagnosis‐of‐influenza‐virus (accessed: September 2025).
55. ISO 22196:2011– Measurement of Antibacterial Activity on Plastics and Other Non‐Porous Surfaces (Edition 2 2011) 2011.
56. ISO 21702:2019 – Measurement of Antiviral Activity on Plastics and Other Non‐Porous Surfaces (Edition 1 2019) 2019.